Bulletin Archive
This archived information is dated to the 2011-12 academic year only and may no longer be current.
For currently applicable policies and information, see the current Stanford Bulletin.
This archived information is dated to the 2011-12 academic year only and may no longer be current.
For currently applicable policies and information, see the current Stanford Bulletin.
In this section: Doctor of Philosophy in Stem Cell Biology and Regenerative Medicine |
Up one level: |
Director: Renee A. Reijo Pera
Co-directors: Michael T. Longaker, Theo D. Palmer, Irving L. Weissman
Participating Faculty: Philip A. Beachy (Professor, Institute for Stem Cell Biology and Regenerative Medicine, Department of Developmental Biology and Biochemistry), Michael F. Clarke (Professor, Institute for Stem Cell Biology and Regenerative Medicine and Department of Medicine-Oncology), Maximilian Diehn (Assistant Professor, Institute for Stem Cell Biology and Regenerative Medicine, Stanford Cancer Center and Department of Radiation Oncology), Michael T. Longaker (Professor, Institute for Stem Cell Biology and Regenerative Medicine and Department of Surgery-Plastic/Reconstructive Surgery), Ravindra Majeti (Assistant Professor, Institute for Stem Cell Biology and Regenerative Medicine, Stanford Cancer Center and Department of Medicine-Hematology), Roel Nusse (Professor, Institute for Stem Cell Biology and Regenerative Medicine and Department of Developmental Biology), Theo Palmer, Associate Professor, Institute for Stem Cell Biology and Regenerative Medicine and Department of Neurosurgery), Renee A. Reijo Pera (Professor, Institute for Stem Cell Biology and Regenerative Medicine and Department of Obstetrics & Gynecology), Irving L. Weissman (Professor, Institute for Stem Cell Biology and Regenerative Medicine, Department of Pathology, Developmental Biology and by courtesy, Biology), Marius Wernig (Assistant Professor, Institute for Stem Cell Biology and Regenerative Medicine and Department of Pathology), Joanna Wysocka (Assistant Professor, Institute for Stem Cell Biology and Regenerative Medicine and Department of Chemical and Systems Biology and Developmental Biology)
Program Office: 265 Campus Drive, Suite G3021, Stanford, CA 94305
Mail Code: 94305-5463
Phone: (650) 723-6716
Web Site: http://stemcell.stanford.edu
Email: stemcellphd@stanford.edu
Courses offered by the Program in Stem Cell Biology and Regenerative Medicine are listed under the subject code STEMREM on the Stanford Bulletin's Explore Courses web site.
The Stanford Stem Cell Biology and Regenerative Medicine (SCBRM) program is dedicated to doctoral education that translates basic science to clinical applications, typically referred to as Translational Science, and of intense interest internationally in medical schools and universities. Stem Cell Biology and Regenerative Medicine is crossdisciplinary with advances linked to embryology, developmental and cell biology, neurosciences, cardiovascular biology, genetics, clinical medicine, bioengineering, engineering and computer sciences. The core curriculum is combined with unique research and clinical/professional immersion rotations to provide opportunities for doctoral students to specialize in the broad subject of translational medicine and yet focus specifically on fundamentals of SCBRM. The curriculum combines education in genetics and developmental biology with an introductory laboratory-based stem cell course, an advanced course in stem cell biology and regenerative medicine, and a clinical rotation with alternative opportunities in law, business and/or engineering.
The mission of the SCBRM graduate program is to produce future leaders in translational science through a combination of basic science and clinical/professional immersion. The program aims to be innovative and to change the landscape for graduate education in the biomedical sciences by having the immersion tailored to each student's translational goals. The program accommodates students who wish to focus primarily at the basic science level alongside those who wish to focus specifically on innovation such as a new device to solve a clinical problem. In the former case, the student might seek out a primary mentor affiliated with the basic sciences and take electives that reflect the more basic interest. In the latter case, the student might select an elective with an engineering focus and seek out primary mentorship with a more clinically or engineering focused mentor. In this way, graduates from our doctoral program receive exceptional didactic education and research experience and are well positioned to develop successful translational careers in SCBRM, in line with their passion to improve human health via applications of their knowledge to human health.
© Stanford University - Office of the Registrar. Archive of the Stanford Bulletin 2011-12. Terms of Use | Copyright Complaints